Detalles de la búsqueda
1.
Dietary Habits and Nutrient Deficiencies in a Cohort of European Crohn's Disease Adult Patients.
Int J Mol Sci
; 24(2)2023 Jan 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36675009
2.
Prognostic Role of Mismatch Repair Status, Histotype and High-Risk Pathologic Features in Stage II Small Bowel Adenocarcinomas.
Ann Surg Oncol
; 28(2): 1167-1177, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32761330
3.
Correction: PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instability.
Mod Pathol
; 33(7): 1453, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32132662
4.
PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instability.
Mod Pathol
; 33(7): 1398-1409, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32066859
5.
Usefulness of panoramic 344°-viewing in Crohn's disease capsule endoscopy: a proof of concept pilot study with the novel PillCam™ Crohn's system.
BMC Gastroenterol
; 20(1): 97, 2020 Apr 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32264831
6.
Dietary geraniol ameliorates intestinal dysbiosis and relieves symptoms in irritable bowel syndrome patients: a pilot study.
BMC Complement Altern Med
; 18(1): 338, 2018 Dec 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-30567535
7.
A case of jejunal adenocarcinoma missed at cross-sectional techniques and diagnosed by capsule endoscopy.
Gastrointest Endosc
; 96(5): 870-872, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35917879
8.
Can supplementation of phytoestrogens/insoluble fibers help the management of duodenal polyps in familial adenomatous polyposis?
Carcinogenesis
; 37(6): 600-6, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27207660
9.
Inflammatory Bowel Diseases and Spondyloarthropathies.
J Rheumatol Suppl
; 93: 21-3, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26523049
10.
Loss of miR-101 expression promotes Wnt/ß-catenin signalling pathway activation and malignancy in colon cancer cells.
J Pathol
; 229(3): 379-89, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22930392
11.
Attachment and quality of life in patients with inflammatory bowel disease.
Int J Colorectal Dis
; 29(10): 1291-6, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25034592
12.
The effect of anti-TNF drugs on the intestinal microbiota in patients with spondyloarthritis, rheumatoid arthritis, and inflammatory bowel diseases.
Rheumatol Immunol Res
; 5(1): 27-33, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38571933
13.
Oral Budesonide and low serum albumin levels at surgery are associated with a higher risk of postoperative intra-abdominal septic complications after primary ileocaecal resection for Crohn's disease: A retrospective analysis of 853 consecutive patients.
Dig Liver Dis
; 2024 Apr 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38616140
14.
Estimation of patients affected by inflammatory bowel disease potentially eligible for biological treatment in a real-world setting.
Dig Liver Dis
; 56(1): 29-34, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37147200
15.
Nutritional Biomarkers for the Prediction of Response to Anti-TNF-α Therapy in Crohn's Disease: New Tools for New Approaches.
Nutrients
; 16(2)2024 Jan 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38257172
16.
The contribution of ultrasound in the diagnostic pathway of a symptomatic hepatocellular adenoma arising from ectopic liver.
J Ultrasound
; 2024 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38393453
17.
Adalimumab Clearance, Rather Than Trough Level, May Have Greatest Relevance to Crohn's Disease Therapeutic Outcomes Assessed Clinically and Endoscopically.
J Crohns Colitis
; 18(2): 212-222, 2024 Feb 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37594369
18.
Pan-enteric Capsule Endoscopy to Characterize Crohn's Disease Phenotypes and Predict Clinical Outcomes in Children and Adults: The Bomiro Study.
Inflamm Bowel Dis
; 2024 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38529957
19.
Poor prognostic factors of pharmacokinetic origin predict outcomes in inflammatory bowel disease patients treated with anti-tumor necrosis factor-α.
Front Immunol
; 15: 1342477, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38476237
20.
Corrigendum: Poor prognostic factors of pharmacokinetic origin predict outcomes in inflammatory bowel disease patients treated with anti-tumor necrosis factor-α.
Front Immunol
; 15: 1383704, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38476224